Format

Send to

Choose Destination
Comput Sci Discov. 2013 Nov 21;6(1):014010.

caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine.

Author information

1
Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.
2
Office of Cancer Nanotechnology Research, Center for Strategic Scientific Initiatives, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
3
Essential Software, Inc., Potomac, MD 20854, USA.
4
Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Rockville, MD 20850, USA.

Abstract

The use of nanotechnology in biomedicine involves the engineering of nanomaterials to act as therapeutic carriers, targeting agents and diagnostic imaging devices. The application of nanotechnology in cancer aims to transform early detection, targeted therapeutics and cancer prevention and control. To assist in expediting and validating the use of nanomaterials in biomedicine, the National Cancer Institute (NCI) Center for Biomedical Informatics and Information Technology, in collaboration with the NCI Alliance for Nanotechnology in Cancer (Alliance), has developed a data sharing portal called caNanoLab. caNanoLab provides access to experimental and literature curated data from the NCI Nanotechnology Characterization Laboratory, the Alliance and the greater cancer nanotechnology community.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center